Yahoo Sports' Nate Tice and Charles McDonald believe that New York could draft Colorado's Shedeur Sanders and sign a veteran ...

Every year, a team, regardless of what they did the prior year, aims to “go for it,” regardless of the moves made. The bottom line is the Giants can’t go into next season with just one quarterback on ...

US pharmaceutical giant Eli Lilly has launched its blockbuster diabetes and weight-loss drug, Mounjaro, in India following ...

The search for a veteran QB and for their future has allowed the NY Giants to go for both separately. It's only going to get ...

US pharma giant Eli Lilly's Mounjaro can prove crucial in treatment of obesity & type 2 diabetes. Launched in the US in 2022, ...

U.S.-based pharmaceutical giant Eli Lilly has officially launched its widely popular drug, Mounjaro, in India. Containing the ...

With the growing demand for weight-loss solutions, many individuals in India have resorted to purchasing obesity drugs from ...

US giant, Eli Lilly launched Mounjaro (tirzepatide) which is a prescription medicine for adults with type 2 diabetes used ...

Pharma giant Eli Lilly has launched Mounjaro, a popular weight-loss drug, in India. Priced at Rs 3,500 for 2.5 mg and Rs 4,375 for 5 mg, Mounjaro is a ...

Starting at Rs 3,500 per injection, with a monthly cost of up to Rs 14,000, Mounjaro enters India’s growing diabetes and ...

An analyst has cited the New York Giants as a cautionary tale for the New England Patriots heading into the NFL Draft.

Novo and Lilly’s campaigns are not limited to advertisements alone, and both companies are trying to raise awareness around obesity through research studies and conferences.